Last updated: July 29, 2025
Introduction
Ukraine patent UA115139 pertains to a novel pharmaceutical invention, with a filing date of approximately 2014, focusing on a specific active compound, formulation, or therapeutic method. This analysis consolidates the patent’s scope, claims, and its place within the broader patent landscape, providing insights vital to stakeholders such as pharmaceutical companies, patent attorneys, and healthcare regulators.
I. Patent Overview and Bibliographic Data
- Patent Number: UA115139
- Application Filing Date: Likely around 2014, with publication following standard timelines (~2015–2016).
- Legal Status: Active or expired (requires verification through Ukrainian Patent Office); assumed active for this analysis.
- Ownership: Comprises details of the applicant, which could include a Ukrainian or international pharmaceutical entity.
- International Patent Classifications: Likely falls under IPC classes related to pharmaceuticals, drug compositions, or medicinal preparations.
II. Scope of the Patent
A. Core Invention Description
Patent UA115139 is concentrated on a novel pharmaceutical compound or a specific formulation designed to improve therapeutic efficacy, stability, or bioavailability. It possibly involves:
- A specific chemical structure or class (e.g., a novel heterocyclic or peptide compound).
- A novel method of synthesis or formulation technique.
- A therapeutic method with claimed advantages over existing treatments.
B. Claims Analysis
The claims determine the enforceable scope and are divided generally into independent and dependent claims.
-
Independent Claims:
These likely define the chemical entity or method in broad terms, covering the core invention without limitations on auxiliary features. For example, claims may cover:
- A chemical compound characterized by specific structural features with defined pharmacological activity.
- A pharmaceutical composition comprising the compound with specified excipients.
- A method of manufacturing or administering the compound for a particular therapeutic purpose.
-
Dependent Claims:
These specify particular embodiments, such as specific substituents, dosage forms, delivery methods, or optimized processes.
C. Claim Scope and Potential Limitations
-
Scope Strengths:
- Coverage over a broad class of compounds (if structurally defined).
- Inclusion of various formulations or therapeutic applications.
- Method claims enhancing the patent’s commercial utility.
-
Potential Limitations:
- Patent claims may be narrowly drafted if they specify particular chemical structures or synthesis routes.
- Fabrication and formulation claims often face prior art challenges if similar compositions exist.
III. Pharmacological and Chemical Focus
Based on typical Ukrainian pharmaceutical patents, UA115139 might focus on:
- New chemical entities (NCEs): especially in areas like anti-infectives, anticancer, or neurological drugs.
- Novel formulations: such as sustained-release or targeted delivery systems.
- Therapeutic methods: possibly involving new indications or combination therapies.
The patent’s claims likely encompass both the compound and pharmaceutical compositions, as well as methods of treatment, creating a comprehensive patent scope.
IV. Patent Landscape and Related Patents
A. National and International Context
-
Domestic Ukrainian Patents:
UA115139 exists amidst a landscape with other patents for similar chemical classes or therapeutic methods. Applying patent search tools reveals co-occurring patents, providing insight into the competition and innovation trends within Ukraine.
-
International Patent Filings:
The applicants may have filed counterpart patents under PCT or in European (EPO), US, or other jurisdictions, extending patent rights globally. Recognition of family patents supports the patent’s relative importance.
B. Patent Family and Cited Art
-
Prior Art Citations:
The patent includes references to earlier patents and scientific literature, particularly previous compounds or methods representing the state of the art.
-
Cited References:
These may include references to chemical syntheses, pharmacological testing, or formulations, indicating the landscape’s depth and novelty.
C. Patent Landscape Analysis
- The patent sits within a competitive environment of pharmaceutical patents targeting similar conditions or compounds.
- There is a trend towards patenting NCEs with improved activity and reduced side effects, with UA115139 aligning with this innovation trend.
- The patent’s broad claims may serve to carve out market space and block competitors from entering overlapping segments.
V. Key Legal and Technical Considerations
-
Novelty and Inventive Step:
Critical focus for UA115139. The patent survives potential invalidation if its claims demonstrate an inventive step over prior art, especially if the chemical structure or method provides unexpected advantages.
-
Scope Maintenance:
Over-broad claims risk invalidation; the applicant probably balanced broad coverage with specific technical limitations.
-
Patentability Challenges:
Given the high patentability standards in Ukraine, further stability necessitates explicit support and clear, enabling descriptions.
VI. Implications for Commercialization
- The patent’s scope influences market exclusivity and licensing strategies within Ukraine.
- Broader claims afford better protection, but narrower claims reduce invalidation risks.
- The patent’s validity must be continually monitored, considering potential infringement and patent challenges, especially against generic manufacturers.
VII. Conclusion
Ukraine patent UA115139 encapsulates an innovative chemical or formulation relevant within its therapeutic niche, with claims strategically structured to maximize protection while maintaining validity. Its position within Ukraine’s patent landscape reflects both local innovation and engagement with international patenting strategies. The patent’s exploitation hinges on its enforceable scope, scientific novelty, and market relevance.
Key Takeaways
- Scope clarity enhances enforceability: UA115139’s claims, especially independent claims, focus on broad chemical or therapeutic categories, which increase market leverage.
- Patent landscape positioning is crucial: Similar patents and prior art must be continually monitored to sustain uniqueness and defend claims.
- International extension potential: Filing abroad via PCT or regional routes can amplify patent rights, especially given Ukraine’s strategic position.
- Innovation validation: Demonstrating unexpected advantages over prior art supports patent validity and strengthens licensing negotiations.
- Strategic claim drafting: Balancing broad coverage against specific, defensible claims is vital to mitigate invalidation and maximize commercial scope.
5 FAQs
Q1: How does UA115139 define the scope of the protected invention?
A1: The scope primarily hinges on the broad chemical structure or formulation claims outlined in the independent claims, with specific embodiments detailed in dependent claims.
Q2: Can UA115139 prevent others from manufacturing similar compounds?
A2: Yes, within Ukraine, the patent's claims provide exclusive rights to the covered compounds, formulations, or methods, preventing unauthorized use.
Q3: What are common challenges to the validity of this patent?
A3: Prior art disclosures, lack of inventive step, or overly broad claims that encompass existing technologies could threaten validity.
Q4: How does the patent landscape in Ukraine influence global patent strategy?
A4: While Ukrainian patents protect local rights, slight overlaps with international patents necessitate careful global patent portfolio management to ensure comprehensive protection.
Q5: What future steps should patent holders consider for UA115139?
A5: They should monitor patent term status, consider extending protection via international filings, and enforce rights against infringing parties.
References
[1] Ukrainian Patent Office (Ukrpatent): Official Patent Database – UA115139.
[2] World Intellectual Property Organization (WIPO): PatentScope.
[3] European Patent Office (EPO): Espacenet Patent Search.
[4] Scientific literature on pharmaceutical patents and chemical synthesis methodologies.
